$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 유전자 교정 기술의 생의학적 응용
Biomedical Application of Gene Editing 원문보기

産業技術硏究 : 江原大學校 産業技術硏究所 = Journal of industrial technology, v.42 no.1, 2022년, pp.29 - 36  

박주찬 (College of Pharmacy, Seoul National University) ,  장현기 (Division of Chemical Engineering and Bioengineering, College of Art Culture and Engineering)

Abstract ▼ AI-Helper 아이콘AI-Helper

The CRISPR system has revolutionized gene editing field. Cas9-mediated gene editing such as Indel induction or HDR enable targeted gene disruption or precise correction of mutation. Moreover, CRISPR-based new editing tools have been developed such as base editors. In this review, we focus on gene ed...

Keyword

#CRISPR   #Gene editing   #Disease modeling   #Gene therapy  

표/그림 (4)

참고문헌 (45)

  1. Hsu, Patrick D., Lander, Eric S.,Zhang, F., 2014, Development and？Applications of CRISPR-Cas9 for Genome Engineering, Cell 157:6？1262-1278. 

    상세보기

  2. Jang, H. K., Song, B., Hwang, G. H.,Bae, S., 2020, Current trends？in gene recovery mediated by the CRISPR-Cas system, Exp Mol？Med 52:7 1016-1027. 

    상세보기

  3. Ihry, R. J., Worringer, K. A., Salick, M. R., Frias, E., Ho, D.,？Theriault, K., Kommineni, S., Chen, J., Sondey, M., Ye, C.,？Randhawa, R., Kulkarni, T., Yang, Z., McAllister, G., Russ, C.,？Reece-Hoyes, J., Forrester, W., Hoffman, G. R., Dolmetsch,？R.,Kaykas, A., 2018, p53 inhibits CRISPR-Cas9 engineering in？human pluripotent stem cells, Nat Med 24:7 939-946. 

    상세보기

  4. Haapaniemi, E., Botla, S., Persson, J., Schmierer, B.,Taipale, J.,？2018, CRISPR-Cas9 genome editing induces a p53-mediated DNA？damage response, Nat Med 24:7 927-930. 

    상세보기

  5. Shin, H. Y., Wang, C., Lee, H. K., Yoo, K. H., Zeng, X., Kuhns,？T., Yang, C. M., Mohr, T., Liu, C.,Hennighausen, L., 2017,？CRISPR/Cas9 targeting events cause complex deletions and？insertions at 17 sites in the mouse genome, Nat Commun 8 15464. 

    상세보기

  6. Kosicki, M., Tomberg, K.,Bradley, A., 2018, Repair of？double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements, Nat Biotechnol 36:8 765-771. 

    상세보기

  7. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A.,Liu, D. R.,？2016, Programmable editing of a target base in genomic DNA？without double-stranded DNA cleavage, Nature 533:7603 420-424. 

  8. Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran,？A. H., Bryson, D. I.,Liu, D. R., 2017, Programmable base editing？of AT to GC in genomic DNA without DNA cleavage, Nature？551:7681 464-471. 

  9. Dutta, D., Heo, I.,Clevers, H., 2017, Disease Modeling in Stem？Cell-Derived 3D Organoid Systems, Trends Mol Med 23:5 393-410. 

    상세보기

  10. Yamanaka, S., 2020, Pluripotent Stem Cell-Based Cell？Therapy-Promise and Challenges, Cell Stem Cell 27:4 523-531. 

    상세보기

  11. Rowe, R. G.,Daley, G. Q., 2019, Induced pluripotent stem cells in？disease modelling and drug discovery, Nat Rev Genet 20:7 377-388. 

    상세보기

  12. Wang, H. X., Li, M., Lee, C. M., Chakraborty, S., Kim, H. W.,？Bao, G.,Leong, K. W., 2017, CRISPR/Cas9-Based Genome Editing？for Disease Modeling and Therapy: Challenges and Opportunities？for Nonviral Delivery, Chem Rev 117:15 9874-9906. 

  13. Sebastiano, V., Zhen, H. H., Haddad, B., Bashkirova, E., Melo, S.？P., Wang, P., Leung, T. L., Siprashvili, Z., Tichy, A., Li, J., Ameen,？M., Hawkins, J., Lee, S., Li, L., Schwertschkow, A., Bauer, G.,？Lisowski, L., Kay, M. A., Kim, S. K., Lane, A. T., Wernig, M.,Oro,？A. E., 2014, Human COL7A1-corrected induced pluripotent stem？cells for the treatment of recessive dystrophic epidermolysis bullosa,？Sci Transl Med 6:264 264ra163. 

  14. Niu, X., He, W., Song, B., Ou, Z., Fan, D., Chen, Y., Fan, Y.,Sun,？X., 2016, Combining Single Strand Oligodeoxynucleotides and？CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced？Pluripotent Stem Cells, J Biol Chem 291:32 16576-16585. 

  15. Ortiz-Virumbrales, M., Moreno, C. L., Kruglikov, I., Marazuela, P.,？Sproul, A., Jacob, S., Zimmer, M., Paull, D., Zhang, B., Schadt,？E. E., Ehrlich, M. E., Tanzi, R. E., Arancio, O., Noggle, S.,Gandy,？S., 2017, CRISPR/Cas9-Correctable mutation-related molecular and？physiological phenotypes in iPSC-derived Alzheimer's PSEN2？(N141I) neurons, Acta Neuropathol Commun 5:1 77. 

    상세보기

  16. Steyer, B., Bu, Q., Cory, E., Jiang, K., Duong, S., Sinha, D.,？Steltzer, S., Gamm, D., Chang, Q.,Saha, K., 2018, Scarless Genome？Editing of Human Pluripotent Stem Cells via Transient Puromycin？Selection, Stem Cell Reports 10:2 642-654. 

  17. Li, X. L., Li, G. H., Fu, J., Fu, Y. W., Zhang, L., Chen, W.,？Arakaki, C., Zhang, J. P., Wen, W., Zhao, M., Chen, W. V.,？Botimer, G. D., Baylink, D., Aranda, L., Choi, H., Bechar, R.,？Talbot, P., Sun, C. K., Cheng, T.,Zhang, X. B., 2018, Highly？efficient genome editing via CRISPR-Cas9 in human pluripotent？stem cells is achieved by transient BCL-XL overexpression,？Nucleic Acids Res 46:19 10195-10215. 

  18. Shahryari, A., Moya, N., Siehler, J., Wang, X., Burtscher,？I.,Lickert, H., 2021, Increasing Gene Editing Efficiency for？CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells, Crispr？j 4:4 491-501. 

  19. Howden, S. E., McColl, B., Glaser, A., Vadolas, J., Petrou, S.,？Little, M. H., Elefanty, A. G.,Stanley, E. G., 2016, A Cas9 Variant？for Efficient Generation of Indel-Free Knockin or Gene-Corrected？Human Pluripotent Stem Cells, Stem Cell Reports 7:3 508-517. 

    상세보기

  20. Yang, D., Scavuzzo, M. A., Chmielowiec, J., Sharp, R., Bajic,？A.,Borowiak, M., 2016, Enrichment of G2/M cell cycle phase in？human pluripotent stem cells enhances HDR-mediated gene repair？with customizable endonucleases, Sci Rep 6 21264. 

    상세보기

  21. Riesenberg, S.,Maricic, T., 2018, Targeting repair pathways with？small molecules increases precise genome editing in pluripotent？stem cells, Nat Commun 9:1 2164. 

    상세보기

  22. Martin, R. M., Ikeda, K., Cromer, M. K., Uchida, N., Nishimura,？T., Romano, R., Tong, A. J., Lemgart, V. T., Camarena, J.,？Pavel-Dinu, M., Sindhu, C., Wiebking, V., Vaidyanathan, S.,？Dever, D. P., Bak, R. O., Laustsen, A., Lesch, B. J., Jakobsen,？M. R., Sebastiano, V., Nakauchi, H.,Porteus, M. H., 2019, Highly？Efficient and Marker-free Genome Editing of Human Pluripotent？Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated？Homologous Recombination, Cell Stem Cell 24:5 821-828.e825. 

    상세보기

  23. Kim, K. T., Park, J. C., Jang, H. K., Lee, H., Park, S., Kim, J.,？Kwon, O. S., Go, Y. H., Jin, Y., Kim, W., Lee, J., Bae, S.,Cha,？H. J., 2020, Safe scarless cassette-free selection of genome-edited？human pluripotent stem cells using temporary drug resistance,？Biomaterials 262 120295. 

    상세보기

  24. Lee, M. O., Moon, S. H., Jeong, H. C., Yi, J. Y., Lee, T. H.,？Shim, S. H., Rhee, Y. H., Lee, S. H., Oh, S. J., Lee, M. Y., Han,？M. J., Cho, Y. S., Chung, H. M., Kim, K. S.,Cha, H. J., 2013,？Inhibition of pluripotent stem cell-derived teratoma formation by？small molecules, Proc Natl Acad Sci U S A 110:35 E3281-3290. 

    상세보기

  25. Kim, K. T., Jeong, H. C., Kim, C. Y., Kim, E. Y., Heo, S. H., Cho, S. J., Hong, K. S.,Cha, H. J., 2017, Intact wound repair activity？of human mesenchymal stem cells after YM155 mediated selective？ablation of undifferentiated human embryonic stem cells, J Dermatol？Sci 86:2 123-131. 

  26. Rees, H. A.,Liu, D. R., 2018, Base editing: precision chemistry on？the genome and transcriptome ofliving cells, Nature Reviews？Genetics 19:12 770-788. 

  27. Song, M., Kim, H. K., Lee, S., Kim, Y., Seo, S.-Y., Park, J., Choi,？J. W., Jang, H., Shin, J. H., Min, S., Quan, Z., Kim, J. H., Kang,？H. C., Yoon, S.,Kim, H. H., 2020, Sequence-specific prediction of？the efficiencies of adenine and cytosine base editors, Nature？Biotechnology 38:9 1037-1043. 

  28. Park, J. C., Jang, H. K., Kim, J., Han, J. H., Jung, Y., Kim, K.,？Bae, S.,Cha, H. J., 2022, High expression of uracil DNA glycosylase？determines C to T substitution in human pluripotent stem cells, Mol？Ther Nucleic Acids 27 175-183. 

    상세보기

  29. Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M.,？Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H.,Liu,？D. R., 2017, Improved base excision repair inhibition and？bacteriophage Mu Gam protein yields C:G-to-T:A base editors with？higher efficiency and product purity, Sci Adv 3:8 eaao4774. 

    상세보기

  30. Park, J. C., Kim, J., Jang, H. K., Lee, S. Y., Kim, K. T., Kwon,？E. J., Park, S., Lee, H. S., Choi, H., Park, S. Y., Choi, H. J., Park,？S. J., Moon, S. H., Bae, S.,Cha, H. J., 2022, Multiple isogenic？GNE-myopathy modeling with mutation specific phenotypes from？human pluripotent stem cells by base editors, Biomaterials 282？121419. 

    상세보기

  31. Truong, D. J., Kuhner, K., Kuhn, R., Werfel, S., Engelhardt, S.,？Wurst, W.,Ortiz, O., 2015, Development of an intein-mediated？split-Cas9 system for gene therapy, Nucleic Acids Res 43:13？6450-6458. 

    상세보기

  32. Chen, Y., Zhi, S., Liu, W., Wen, J., Hu, S., Cao, T., Sun, H., Li,？Y., Huang, L., Liu, Y., Liang, P.,Huang, J., 2020, Development of？Highly Efficient Dual-AAV Split Adenosine Base Editor for In Vivo？Gene Therapy, Small Methods 4:9 2000309. 

    상세보기

  33. Keeler, A. M.,Flotte, T. R., 2019, Recombinant Adeno-Associated？Virus Gene Therapy in Light of Luxturna (and Zolgensma and？Glybera): Where Are We, and How Did We Get Here?, Annu Rev？Virol 6:1 601-621. 

  34. Jo, D. H., Jang, H.-K., Cho, C. S., Han, J. H., Ryu, G., Jung,？Y., Bae, S.,Kim, J. H., 2021, Therapeutic adenine base editing？corrects nonsense mutation and improves visual function in a？mouse model of Leber congenital amaurosis, bioRxiv？2021.2001.2007.425822. 

  35. Raguram, A., Banskota, S.,Liu, D. R., 2022, Therapeutic invivo？delivery of gene editing agents, Cell 185:15 2806-2827. 

    상세보기

  36. Jang, H. K., Jo, D. H., Lee, S. N., Cho, C. S., Jeong, Y. K., Jung,？Y., Yu, J., Kim, J. H., Woo, J. S.,Bae, S., 2021, High-purity？production and precise editing of DNA base editing？ribonucleoproteins, Sci Adv 7:35. 

  37. Nahmad, A. D., Reuveni, E., Goldschmidt, E., Tenne, T.,？Liberman, M., Horovitz-Fried, M., Khosravi, R., Kobo, H.,？Reinstein, E., Madi, A., Ben-David, U.,Barzel, A., 2022, Frequent？aneuploidy in primary human T cells after CRISPRCas9 cleavage,？Nature Biotechnology. 

  38. Slesarenko, Y. S., Lavrov, A. V.,Smirnikhina, S. A., 2022,？Off-target effects of base editors: what we know and how we can？reduce it, Curr Genet 68:1 39-48. 

    상세보기

  39. Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G.？A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer,？D. E., Doudna, J. A.,Liu, D. R., 2020, Phage-assisted evolution？of an adenine base editor with improved Cas domain compatibility？and activity, Nature Biotechnology 38:7 883-891. 

    상세보기

  40. Li, S., Yuan, B., Cao, J., Chen, J., Chen, J., Qiu, J., Zhao, X.-M.,？Wang, X., Qiu, Z.,Cheng, T.-L., 2020, Docking sites inside Cas9？for adenine base editing diversification and RNA off-target？elimination, Nature Communications 11:1 5827. 

  41. Paunovska, K., Loughrey, D.,Dahlman, J. E., 2022, Drug delivery？systems for RNA therapeutics, Nature Reviews Genetics 23:5？265-280. 

    상세보기

  42. Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P.,？DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C.,？Clendaniel, V., Amaonye, M., Beach, A., Berth, K., Biswas, S.,？Braun, M. C., Chen, H.-M., Colace, T. V., Ganey, J. D.,？Gangopadhyay, S. A., Garrity, R., Kasiewicz, L. N., Lavoie, J.,？Madsen, J. A., Matsumoto, Y., Mazzola, A. M., Nasrullah, Y. S.,？Nneji, J., Ren, H., Sanjeev, A., Shay, M., Stahley, M. R., Fan,？S. H. Y., Tam, Y. K., Gaudelli, N. M., Ciaramella, G., Stolz, L.？E., Malyala, P., Cheng, C. J., Rajeev, K. G., Rohde, E., Bellinger,？A. M.,Kathiresan, S., 2021, In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates, Nature 593:7859？429-434. 

  43. Rothgangl, T., Dennis, M. K., Lin, P. J. C., Oka, R., Witzigmann,？D., Villiger, L., Qi, W., Hruzova, M., Kissling, L., Lenggenhager,？D., Borrelli, C., Egli, S., Frey, N., Bakker, N., Walker, J. A., Kadina,？A. P., Victorov, D. V., Pacesa, M., Kreutzer, S., Kontarakis, Z.,？Moor, A., Jinek, M., Weissman, D., Stoffel, M., van Boxtel, R.,？Holden, K., Pardi, N., Thony, B., Haberle, J., Tam, Y. K., Semple,？S. C.,Schwank, G., 2021, In vivo adenine base editing of PCSK9？in macaques reduces LDL cholesterol levels, Nature Biotechnology？39:8 949-957. 

    상세보기

  44. Yeh, W.-H., Chiang, H., Rees, H. A., Edge, A. S. B.,Liu, D. R.,？2018, In vivo base editing of post-mitotic sensory cells, Nature？Communications 9:1 2184. 

    상세보기

  45. Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi,？E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B.,？Osborn, M. J., Musunuru, K., Palczewski, K.,Liu, D. R., 2022,？Engineered virus-like particles for efficient invivo delivery of？therapeutic proteins, Cell 185:2 250-265.e216. 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로